References
- Herberman R B. Natural killer cells. Ann Rev Med 1986; 37: 347–52
- Merluzzi V J, Savage D M, Mertelsmann R, Welte K. Generation of nonspecific murine T cells in vitro by purified human interleukin 2. Cell Immunol 1984; 84: 74–84
- Lanier L L, Phillips J H, Hackett J, Tutt M, Kumar V. Natural killer cells: Definition of a cell type rather than a function. J Immunol 1986; 137: 2735–9
- Ochoa A C, Gromo G, Alter B J, Sondel P M, Bach F H. Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, β-IL 1, Interferon-γ and -β. J Immunol 1987; 138: 2728–33
- Grimm E A, Mazumder A, Zhang H, Rosenberg S A. Lymphokine-activated killer phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin-2 activated autologous human peripheral blood lymphocytes. J Exp Med 1982; 155: 1823–41
- Rosenberg S A, Lotze M T, Muul L M, Chang A E, Avis F P, Leitman S, Linehan W M, Robertson C N, Lee R E, Rubin J T, Seipp C A, Simpson C G, White D E. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high dose interleukin-2 alone. N Engl J Med 1987; 316: 889–97
- Brunner K T, Mauel J, Cerottini J C, Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogeneic target cells in vitro inhibition by isoantibody and by drugs. Immunology 1968; 14: 181–96
- Cerottini J C, Brunner K T. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol 1974; 18: 67–132
- Klein G, Perlmann P. In vitro cytotoxic effect of isoantibody measured as isotope release from labelled target cell DNA. Nature 1963; 199: 451–3
- Jagarlamoody S M, Aust J C, Tew R H, McKhann C F. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique. Proc Nat Acad Sci USA 1971; 68: 1346–50
- Tagliabue A, Mantovani A, Boraschi D, Herberman R B. Species-restricted effects of human and mouse lymphokines on macrophages. Eur J Immunol 1980; 10: 542–6
- Keilholz U, Welters H, Dummer R, Tilgen W, Hunstein W. Ein neuer Weg in der Behandlung metastasierender Melanome: Adoptive Immun-therapie mit Lymphokin-aktivierten Killerzellen. Hautarzt 1988; 39: 378–81